Precision BioSciences Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Precision BioSciences Inc had 99.37M in cash and cash equivalents.

Precision BioSciences Inc reported 62.17M in total liabilities as of the latest reported quarter, including 8.91M in current liabilities and 53.26M in non-current liabilities.

As of the latest reported quarter, Precision BioSciences Inc's total assets were 154.42M, consisting of 118.74M in current assets and 35.68M in non-current assets.

Precision BioSciences Inc reported 92.25M in total shareholders' equity as of the latest reported quarter.